Header cover image

Brazilian (BOVESPA) Healthcare Sector Analysis

UpdatedJun 22, 2024
DataAggregated Company Financials
Companies17
  • 7D-2.1%
  • 3M-9.3%
  • 1Y-27.9%
  • YTD-17.1%

Over the last 7 days, the Healthcare industry has dropped 2.1%, driven by a pullback from Rede D'Or São Luiz of 2.2%. Overall the industry is down 28% in 12 months. Earnings are forecast to grow by 27% annually.

Sector Valuation and Performance

Has the Brazilian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 23 Jun 2024R$134.2bR$142.9bR$4.2b11.5x32.1x0.9x
Tue, 21 May 2024R$156.4bR$142.9bR$4.2b12.1x37.5x1.1x
Thu, 18 Apr 2024R$128.9bR$140.0bR$3.2b11.5x40.7x0.9x
Sat, 16 Mar 2024R$145.0bR$133.3bR$2.6b14.6x55x1.1x
Mon, 12 Feb 2024R$148.3bR$132.9bR$2.7b17x54.7x1.1x
Wed, 10 Jan 2024R$167.7bR$135.0bR$2.9b20.3x58.2x1.2x
Fri, 08 Dec 2023R$162.3bR$135.0bR$2.9b20.2x56.3x1.2x
Sun, 05 Nov 2023R$151.1bR$126.2bR$2.8b18x54.4x1.2x
Tue, 03 Oct 2023R$163.7bR$126.1bR$2.7b18.4x59.6x1.3x
Thu, 31 Aug 2023R$176.4bR$126.1bR$2.7b20.8x64.2x1.4x
Sat, 29 Jul 2023R$197.7bR$117.1bR$2.9b16x68.9x1.7x
Mon, 26 Jun 2023R$185.7bR$116.7bR$2.8b16.3x65.9x1.6x
Wed, 24 May 2023R$161.8bR$110.8bR$2.8b14.9x58.8x1.5x
Fri, 21 Apr 2023R$132.6bR$106.3bR$3.3b14.5x39.9x1.2x
Sun, 19 Mar 2023R$133.0bR$104.5bR$3.7b14.2x35.8x1.3x
Tue, 14 Feb 2023R$169.6bR$98.3bR$4.2b15.3x40.7x1.7x
Thu, 12 Jan 2023R$167.6bR$98.3bR$4.2b15.5x40.2x1.7x
Sat, 10 Dec 2022R$154.4bR$98.3bR$4.2b14.3x37x1.6x
Mon, 07 Nov 2022R$205.3bR$91.0bR$4.6b17.3x44.6x2.3x
Wed, 05 Oct 2022R$202.7bR$90.4bR$4.6b17.1x44.1x2.2x
Fri, 02 Sep 2022R$199.5bR$90.2bR$4.4b14x45x2.2x
Sun, 31 Jul 2022R$184.1bR$84.2bR$5.2b13.8x35.1x2.2x
Tue, 28 Jun 2022R$166.8bR$84.2bR$5.2b12.5x31.9x2x
Thu, 26 May 2022R$191.7bR$83.2bR$5.4b13.3x35.5x2.3x
Sat, 23 Apr 2022R$230.8bR$78.1bR$5.6b14.1x40.9x3x
Mon, 21 Mar 2022R$308.5bR$88.0bR$5.7b13x54.1x3.5x
Wed, 16 Feb 2022R$273.3bR$87.0bR$5.7b14.4x47.8x3.1x
Fri, 14 Jan 2022R$236.0bR$87.0bR$5.7b15.1x41.2x2.7x
Sun, 12 Dec 2021R$271.5bR$87.0bR$5.7b16.9x47.5x3.1x
Tue, 09 Nov 2021R$301.3bR$84.2bR$6.1b19.4x49.6x3.6x
Thu, 07 Oct 2021R$325.0bR$82.0bR$6.0b21.5x54.5x4x
Sat, 04 Sep 2021R$358.6bR$82.0bR$6.0b24.3x60.1x4.4x
Mon, 02 Aug 2021R$341.7bR$73.0bR$5.8b22.7x58.9x4.7x
Price to Earnings Ratio

60.2x


Total Market Cap: R$349.1bTotal Earnings: R$5.8bTotal Revenue: R$73.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Healthcare Sector Price to Earnings3Y Average 48.4x202220232024
Current Industry PE
  • Investors are pessimistic on the Brazilian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 32.1x which is lower than its 3-year average PE of 48.4x.
  • The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 0.94x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 10% per year over the last three years.
  • Meanwhile revenues for these companies have grown 25% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Brazilian Healthcare sector?

BR Market1.37%
Healthcare-2.10%
Medical Equipment3.09%
Pharma0.88%
Healthtech0%
Life Sciences0%
Biotech-2.14%
Healthcare Services-2.60%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 96.7x.
    • Analysts are expecting annual earnings growth of 29.0%, which is lower than the prior year's growth of 63.3% per year.
  • Investors are most pessimistic about the Medical Equipment industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 29% over the next 5 years.
  • However this is lower than its past earnings growth rate of 63% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 11% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ODPV3 OdontoprevR$11.543.2%
+R$198.2m
-3.8%PE12.3x
HYPE3 HyperaR$29.051.1%
+R$196.2m
-33.6%PE10.8x
AALR3 Alliança Saúde e ParticipaçõesR$10.003.1%
+R$35.5m
-57.5%PS1x
FLRY3 FleuryR$14.210.07%
+R$5.5m
-11.9%PE15.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

HYPE3

R$29.05

Hypera

7D

1.1%

1Y

-33.6%

MATD3

R$4.66

Hospital Mater Dei

7D

-4.3%

1Y

-58.2%

DASA3

R$2.98

Diagnósticos da América

7D

-29.4%

1Y

-73.4%

RDOR3

R$26.35

Rede D'Or São Luiz

7D

-2.2%

1Y

-21.0%

ONCO3

R$5.80

Oncoclínicas do Brasil Serviços Médicos

7D

-4.3%

1Y

-40.8%

VVEO3

R$2.03

CM Hospitalar S/A

7D

-5.1%

1Y

-89.9%

AALR3

R$10.00

Alliança Saúde e Participações

7D

3.1%

1Y

-57.5%

HAPV3

R$3.67

Hapvida Participações e Investimentos

7D

-2.1%

1Y

-15.2%

BLAU3

R$9.64

Blau Farmacêutica

7D

-3.5%

1Y

-54.8%